RECENT NEWS

2015 November 2

November 27 –  28, 2015 Grand Hotel Salerno – Sala Cilento via Lungomare Tafuri, 1, 84127 Salerno

2015 February 26

2015/02/20 Aula F. Ferro – Polo Universitario Azienda Ospedaliera – Universitaria “San Giovanni Di Dio e Ruggi D’Aragona”…

2015 February 12

AEPC 2015 49th Annual Meeting of the Association for European Paediatric and Congenital Cardiology. May 20-23 – 2015…

Steering Committee

The Steering Committee is responsible for the overall direction and management of the Consortium including management of the Cores and Committees and membership of the Consortium.

Simon Body
Chairperson

Dr. Body is an Associate Professor of Anesthesiology at Harvard Medical School and a cardiac anesthesiologist with research expertise in genomics of bicuspid aortic valve disease and atrial fibrillation.
Dr. Body’s clinical responsibilities at Brigham and Women’s Hospital include cardiac anesthesia and transesophageal echocardiography. Dr. Body mentors cardiac anesthesia fellows and residents who have a special interest in genetics, and medical students. Dr. Body is Principal Investigator for the Bicuspid Aortic Valve Consortium (BAVCon) and the Perioperative Genomics Research Network (PeriGReN).

Arturo Evangelista

Arturo Evangelista director of Aortic Diseases Unit of Hospital Vall d´Hebron in Barcelona from 2005 is the coordinator of the Spanish network of research on aortic aneurysms. Bicuspid aortic valve, from genetic to management, is one of the main objectives.
We are experts in multimodality imaging in aortic diseases and we use a clinical and imaging protocol in the follow-up of more than 400 bicuspid aortic valve patients.
We have received several grants from the Spanish Ministry of Health to investigate the relationship between this valve disorder and ascending aorta dilation based on genetics, biomechanics and biomolecular studies. Hemokinetic assessment of ascending aorta flow by 4D-MRI or tissue characterization of aortic valve deterioration by MDCT are currently investigated in more than 500 patients. We coordinate the BICATOR trial with the aim to assess the beneficial effect of atorvastatin treatment in valvular deterioration and ascending aorta dilation in bicuspid aortic valve.
In 2012 we collaborate with Simon Body in to launch BAVCON and co-coordinate the imaging core of the consortium

Eric Isselbacher
Alessandro Della Corte

Prof. Alessandro Della Corte achieved his Cardiac Surgery Specialty Degree in 2004 and PhD Degree in 2008 at the Second University of Naples, Italy (UN2). Assistant Professor in 2006 and Associate Professor in 2014, he currently teaches in several courses, and has been supervisor for PhD programs in other Italian and foreign Institutions.
Since 2007: Staff Surgeon at the Cardiac Surgery Unit of the Monaldi Hospital, Naples, with particular interest in surgery of the aorta and aortic valve, also co-running the aortic endovascular treatment program.
He has run four nationwide research projects co-funded by the Italian Ministry of Research and is currently PI in a national multidisciplinary project on bicuspid aortic valve aortopathy, co-funded by the Italian Ministry of Health.
Author of more than 110 abstracts and 105 papers published in international peer-review journals; co-author of 1 monography and 3 book chapters; fellow of the Italian Society for Cardiac Surgery and European Association for Cardiothoracic Surgery; reviewer for 15 international scientific Journals.

Dianna Milewicz
Eduardo Bossone

He is currently the Director of “Cava the Tirreni and Amalfi Cost” Division of Cardiology, University Hospital, Salerno, Italy. Research interests: Aortic diseases, right heart-pulmonary circulation unit physiopathology, Takotsubo syndrome. IRAD and IRAD-biomarkers investigator, Task Force Member of 2014 ESC Guidelines on Aortic Diseases. BAVcon Steering Committee Member.

Giuseppe Limongelli

Dr. Giuseppe Limongelli graduated (1997) and completed his Cardiology Training (2001) at the Second University of Naples (SUN). From 2002 to 2003, he was Research Fellow of The Genotyping Lab & Heart Failure Clinic at St George’s Hospital Medical School (London, UK). From 2003 to 2004, he was Research Fellow of the Cobbold Lab (Middlesex Hospital) & Heart Failure Clinic (The Heart Hospital) University College of London (London, UK). He completed a 3 year Phd course at Secondd University of Naples in 2003. He was appointed with the title of “European Doctor in Biotechnology” in 2007 (HeduBT, UK). He is a member/fellow of national and international cardiovascular societies (SIC; ESC; HFA; AHA). Since February 2011, he is Editor in Chief of a new open access, online journal, Cardiogenetics. Since 2013, he is member of the World Association of Medical Editors (WAME). He is currently an assistant professor of cardiology at the Second University of Naples, and consultant cardiologists, at the Department of Cardiology, Monaldi Hospital. His main interests concern the field of inherited heart diseases, congenital heart diseases, and rare cardiovascular diseases.

Hector Michelena
Kim Eagle

Dr. Kim Eagle is the founder of the International Registry of Aortic Dissection which began 18 years ago and currently is enrolling patients at 41 centers around the world. More than 6,000 subjects have enrolled in the IRAD registry and nearly 80 publications on this acute aortic syndrome have been accrued. Dr. Eagle is also the chair of the GenTAC registry which is a NIH based study of presumed genetically mediated aortic conditions currently involved 8 sites in the United States. GenTAC which has enrolled nearly 4,000 subjects includes nearly 1,000 patients to have bicuspid aortic valve disease and related aortapathy. Dr. Eagle has worked with BAVCon leadership to make these subjects available for inclusion in the BAVCon collaborative. Furthermore, since both imaging and biological samples are available on this group of individuals, this to can be made available to support scientific collaborative studies involving bicuspid aortic valve disease.

Patrick Mathieu
Philippe Pibarot
Thor Sundt
Yohan Bosse

Dr. Yohan Bossé completed a bachelor at Moncton University in 1999, and then a Master and a PhD in Genetics at Laval University in 2001 and 2004, respectively. He then completed a postdoctoral training (2004-2007) at McGill University and Génome Québec Innovation Centre to refine his skills and expertise in genomic research. Dr. Bossé is currently Associate Professor in the department of Molecular Medicine, Faculty of Medicine at Laval University. He is a research scientist affiliated with the “Institut universitaire de cardiologie et de pneumologie de Québec” where he is leading a translational genomic research program on cardio-respiratory diseases. He is holding a grant from the Canadian Institutes of Health Research (2014-2017) entitled: Genetics and functional genomics to dissect the molecular basis of bicuspid aortic valve.